期刊： CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022; 22 (7)
To clarify the importance of the FISH cut-off value and copy number variation for 1q21 in Chinese newly diagnosed multiple myeloma, we performed a ret......
期刊： CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022; 22 (9)
In the phase 2 study, generic dasatinib produced high rates of MMR early during therapy in newly diagnosed CML-CP patients in China. Fifty-five patien......
期刊： CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022; 22 (4)
TP53 gene mutations are common in myelodysplastic syndromes (MDS). Previous studies have reported their detrimental effects on patient survival. Howev......
期刊： CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022; 22 (5)
Myelofibrosis (MF) is a BCR-ABL1-negative myeloproliferative neoplasm characterized by anemia, extramedullary hematopoiesis, bone marrow fibrosis, spl......
期刊： CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022; 22 (6)
This study aimed to analyze the CSF3R mutations (CSF3R(mut)) in AML with recurrent genetic abnormalities for potential synergistic pathomechanism in 1......
期刊： CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022; 22 (1)
Using the SEER database, we identified 3877 patients with APL diagnosed from 20 00 to 2014, including 465 s-APL and 3412 dn-APL. Compared with dn-APL,......
期刊： CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022; 22 (2)
Consensus lacks regarding the association between diabetes mellitus (DM) and the prognosis of patients with non-Hodgkin lymphoma (NHL). We performed a......
期刊： CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021; 21 (4)
Bone marrow necrosis (BMN) is a rare secondary event of many discrepant neoplastic processes. Between 2005 and 2019, 23 cases of BMN were detected and......
期刊： CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021; 21 (9)
Daratumumab plus bortezomib/dexamethasone (D-Vd) significantly improved outcomes versus Vd in patients with relapsed or refractory multiple myeloma (R......
期刊： CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021; 21 (8)
Adolescents with ALL represent a unique patient population, with a disproportionate survival disadvantage compared with younger patients. We had analy......
